Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins. — Robert W. Jansen (1991) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
Shared by
De Clercq Erik
KU Leuven
Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
Article
1991
en
Authors
+3 more
RJ
Robert W. Jansen
GM
Grietje Molema
RP
Rudi Pauwels
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1993
Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
Rw Jansen
,
Dominique Schols
,
Rudi Pauwels
,
De Clercq Erik
,
Dirk K. F. Meijer
Article
1989
9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): A novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-moloney murine sarcoma virus activity in vivo
Lieve Naesens
,
Jan Balzarini
,
Ivan Rosenberg
,
Antonı́n Holý
,
De Clercq Erik
Article
1999
Anti-HIV-1 Activity of Combinations and Covalent Conjugates of Negatively Charged Human Serum Albumins (NCAs) and AZT
Miriam E. Kuipers
,
Pieter Swart
,
Myriam Witvrouw
,
José A. Esté
,
D. Reymen
,
De Clercq Erik
,
Dirk K. F. Meijer
Article
1989
Coumermycin A1 is a potent inhibitor of human immunodeficiency virus (HIV) replication in vitro
Masanori Baba
,
Rudi Pauwels
,
Jan Balzarini
,
Dominique Schols
,
De Clercq Erik
Article
1994
Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro
Masanori Baba
,
Shirô Shigeta
,
Satoshi Yuasa
,
Hideaki Takashima
,
Kouichi Sekiya
,
Masaru Ubasawa
,
H. TANAKA
,
T. MIYASAKA
,
Richard Walker
,
De Clercq Erik
Discussion(0)
No comments yet. Be the first to comment.